Fate Therapeutics, Inc. Share Price
FATEFate Therapeutics, Inc. Stock Performance
Open $1.06 | Prev. Close $1.03 | Circuit Range N/A |
Day Range $1.02 - $1.06 | Year Range $0.66 - $1.93 | Volume 42,119 |
Average Traded $1.03 |
Fate Therapeutics, Inc. Share Price Chart
About Fate Therapeutics, Inc.
Fate Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops programmed cellular immunotherapies for cancer and immune disorders in the United States and internationally. The company's chimeric antigen receptor (CAR)-targeted NK and T-cell product candidates include FT576 to treat multiple myeloma; FT836 whiuch is in preclinical stage for multiple tumor types; and FT522, to treat B-cell Lymphoma and autoimmunity. Its CAR T-cell programs include FT819 to treat systemic lupus erythematosus, and FT825 to treat solid tumors.It has a collaboration and option agreement with Ono Pharmaceutical Co. Ltd. for the development and commercialization of off-the-shelf, iPSC-derived CAR T-cell product candidates for the treatment of solid tumors. Fate Therapeutics, Inc. was incorporated in 2007 and is headquartered in San Diego, California.
Fate Therapeutics, Inc. Historical Data
| Day | Open | Close | Change % |
|---|---|---|---|
12-Jan-26 | $1.06 | $1.07 | +2.87% |
09-Jan-26 | $1.08 | $1.04 | -2.34% |
08-Jan-26 | $1.10 | $1.07 | -2.73% |
07-Jan-26 | $1.03 | $1.10 | +8.91% |
06-Jan-26 | $1.00 | $1.01 | -0.39% |
05-Jan-26 | $0.99 | $1.01 | +3.15% |
02-Jan-26 | $1.00 | $0.98 | -0.10% |
FAQs on Fate Therapeutics, Inc. Share Price
Can I buy Fate Therapeutics, Inc. shares in India?
What is the share price of Fate Therapeutics, Inc.?
What is the 5 year returns of Fate Therapeutics, Inc.?
What are the high & low stock price of Fate Therapeutics, Inc. today?
What is the 52-week high and low of Fate Therapeutics, Inc. stock?